Date: November 15, 2005
Creator: Carter, J C; Wilson, T S; Alvis, R M; Paulson, C N; Setlur, U S; McBride, M T et al.
Description: Stroke is a major cause of mortality and is the primary cause of long-term disability in the United States. A recent study of Stroke incidence, using conservative calculations, suggests that over 700,000 people annually in this country will have a stroke. Of these 700,000, approximately 150,000 will die and 400,000 will be left with a significant deficit; only one quarter will return to an independent--although not necessarily baseline--level of functioning. The costs of caring for victims of stroke in the acute phase, chronic care, and lost productivity amount to 40 billion per year. Of all strokes, approximately 20% are hemorrhagic and 20% are due to small vessel disease. Thus, the number of people with large vessel thromboembolic disease and the target population of this research is greater than 400,000. Currently, the only approved therapy for treatment of acute ischemic stroke is intravenous thrombolytic drugs. While stroke patients who receive these drugs are more likely to have better outcomes than those who do not, their improvement is highly dependent on the initiation of treatment within three hours of the onset of symptoms, with an increased risk of intracranial hemorrhage if the medication is begun outside this time window. With this rigid ...
Contributing Partner: UNT Libraries Government Documents Department